The Emmes Group Appoints Dr. Rama Kondru as Chief Executive Officer

Go back to Newsroom

The Emmes Group Appoints Dr. Rama Kondru as Chief Executive Officer

ROCKVILLE, Maryland- The Emmes Group today announced that its Board of Directors has appointed Dr. Rama Kondru as Chief Executive Officer, reflecting the company's commitment to advancing next-generation clinical trials that improve quality, speed, and patient outcomes.
This appointment reflects the Board's confidence in Dr. Kondru's ability to drive innovation and operational excellence and underscores its commitment to advancing clinical research through scientific excellence, technology, and artificial intelligence.

Download Go back to Newsroom

Transcriptomic and proteomic signatures following AS03-adjuvanted Influenza A/H7N9 vaccine

Go back to Resources

Transcriptomic and proteomic signatures following AS03-adjuvanted Influenza A/H7N9 vaccine

Authors:

Volume:

Journal:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

The brain as an HIV reservoir: Recent findings using autopsy tissues from people with HIV

Go back to Resources

The brain as an HIV reservoir: Recent findings using autopsy tissues from people with HIV

Authors:

Volume:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial

Go back to Resources

Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial

Go back to Resources

Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Collaborative care intervention for risky opioid use among primary care patients: The STOP randomized clinical trial

Go back to Resources

Collaborative care intervention for risky opioid use among primary care patients: The STOP randomized clinical trial

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Cure Sickle Cell Initiative recommendations on common data elements for sickle cell disease gene therapy trials

Go back to Resources

Cure Sickle Cell Initiative recommendations on common data elements for sickle cell disease gene therapy trials

Authors:

Volume:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

A remote intervention to improve medication nonadherence guided by a marker of risk derived from the electronic health records of adolescent transplant recipients

Go back to Resources

A remote intervention to improve medication nonadherence guided by a marker of risk derived from the electronic health records of adolescent transplant recipients

Authors:

Journal:

PMID:

URL:

DOI:

Abstract:

Go back to Resources

Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children

Go back to Resources

Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children

Authors:

Volume:

Issue:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Outcomes in pediatric recipients of ABO-incompatible liver transplants: An analysis of the SPLIT Registry

Go back to Resources

Outcomes in pediatric recipients of ABO-incompatible liver transplants: An analysis of the SPLIT Registry

Authors:

Journal:

PMID:

URL:

DOI:

Keywords:

Abstract:

Go back to Resources

Subscribe to